Kronos Bio Inc. (KRON): Price and Financial Metrics

Kronos Bio Inc. (KRON): $0.86

0.01 (+1.18%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add KRON to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#33 of 329

in industry

KRON Price/Volume Stats

Current price $0.86 52-week high $1.60
Prev. close $0.85 52-week low $0.69
Day low $0.85 Volume 249,100
Day high $0.87 Avg. volume 270,378
50-day MA $0.94 Dividend yield N/A
200-day MA $1.05 Market Cap 51.89M

KRON Stock Price Chart Interactive Chart >


Kronos Bio Inc. (KRON) Company Bio


Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib, a selective inhibitor targeting spleen tyrosine kinase in acute myeloid leukemia patients. The company is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors. Kronos Bio, Inc. is founded in 2017 and is headquartered in San Mateo, California.


KRON Latest News Stream


Event/Time News Detail
Loading, please wait...

KRON Latest Social Stream


Loading social stream, please wait...

View Full KRON Social Stream

KRON Price Returns

1-mo -4.46%
3-mo -12.24%
6-mo 13.80%
1-year -30.65%
3-year -94.04%
5-year N/A
YTD -31.20%
2023 -22.84%
2022 -88.08%
2021 -54.50%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!